Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning ; volume:15 ; number:1 ; day:4 ; month:10 ; year:2023 ; pages:1-23 ; date:12.2023
Genome medicine ; 15, Heft 1 (4.10.2023), 1-23, 12.2023
- Urheber
-
Neumann, Alexander
Ohlei, Olena
Küçükali, Fahri
Bos, Isabelle J.
Timsina, Jigyasha
Vos, Stephanie
Prokopenko, Dmitry
Tijms, Betty M.
Andreasson, Ulf
Blennow, Kaj
Vandenberghe, Rik
Scheltens, Philip
Teunissen, Charlotte E.
Engelborghs, Sebastiaan
Frisoni, Giovanni B.
Blin, Oliver
Richardson, Jill C.
Bordet, Régis
Lleó, Alberto
Alcolea, Daniel
Popp, Julius
Marsh, Thomas W.
Gorijala, Priyanka
Clark, Christopher
Peyratout, Gwendoline
Martinez-Lage, Pablo
Tainta, Mikel
Dobson, Richard J. B.
Legido-Quigley, Cristina
Broeckhoven, Christine Van
Tanzi, Rudolph E.
Kate, Mara ten
Lill, Christina M.
Barkhof, Frederik
Cruchaga, Carlos
Lovestone, Simon
Streffer, Johannes
Zetterberg, Henrik
Visser, Pieter Jelle
Sleegers, Kristel
Bertram, Lars
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13073-023-01233-z
- URN
-
urn:nbn:de:101:1-2024020809070869806092
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Neumann, Alexander
- Ohlei, Olena
- Küçükali, Fahri
- Bos, Isabelle J.
- Timsina, Jigyasha
- Vos, Stephanie
- Prokopenko, Dmitry
- Tijms, Betty M.
- Andreasson, Ulf
- Blennow, Kaj
- Vandenberghe, Rik
- Scheltens, Philip
- Teunissen, Charlotte E.
- Engelborghs, Sebastiaan
- Frisoni, Giovanni B.
- Blin, Oliver
- Richardson, Jill C.
- Bordet, Régis
- Lleó, Alberto
- Alcolea, Daniel
- Popp, Julius
- Marsh, Thomas W.
- Gorijala, Priyanka
- Clark, Christopher
- Peyratout, Gwendoline
- Martinez-Lage, Pablo
- Tainta, Mikel
- Dobson, Richard J. B.
- Legido-Quigley, Cristina
- Broeckhoven, Christine Van
- Tanzi, Rudolph E.
- Kate, Mara ten
- Lill, Christina M.
- Barkhof, Frederik
- Cruchaga, Carlos
- Lovestone, Simon
- Streffer, Johannes
- Zetterberg, Henrik
- Visser, Pieter Jelle
- Sleegers, Kristel
- Bertram, Lars
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
The “rights” of precision drug development for Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
The plasma peptides of Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
The “rights” of precision drug development for Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
The plasma peptides of Alzheimer’s disease
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
The “rights” of precision drug development for Alzheimer’s disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Clinical Features of Patients with Alzheimer’s Disease and a History of Traumatic Brain Injury
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders